Drugs for Chronic Heart Failure
Date: June 14, 2021
Issue #:
1626Summary:
Among patients with chronic heart failure, those with
a left ventricular ejection fraction (LVEF)≤40% are
considered to have heart failure with reduced ejection
fraction (HFrEF). Patients with a LVEF≥50% are
considered to have heart failure with preserved ejection
fraction (HFpEF). Those with a LVEF of 41-49% are an
intermediate group more similar to patients with HFpEF.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: admin Tags: Accupril ACE inhibitors Aldactone Altace ARBs Atacand Beta blockers BiDil Bisoprolol Bumetanide Burinex Candesartan Captopril Carvedilol cilazapril Coreg Corlanor Coversyl Cozaar dapagliflozin Digoxin Diovan Diu Source Type: research
More News: Accupril | Beta-Blockers | Bisoprolol | Bumetanide | Captopril | Cardiology | Coreg | Cozaar | Dapagliflozin | Diovan | Drugs & Pharmacology | Forxiga | Heart | Heart Failure | Losartan | Quinapril